Burkehill Global Management, LP
Position in LXEO — Lexeo Therapeutics, Inc.
CIK 1904549
NEW YORK, NY
Position in LXEO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$717,500
-$523,750 QoQ
Shares Held
125,000
0.0% QoQ
Ownership
0.159%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Burkehill Global Management, LP holds $177,167,577 across 62 Biotechnology names. LXEO ranks #53 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
675,000 | $25,980,750 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
35,000 | $11,276,650 | |
| 3 | RAPP |
Rapport Therapeutics, Inc.
|
250,000 | $7,822,500 | |
| 4 | NUVL |
Nuvalent, Inc.
|
70,000 | $7,171,500 | |
| 5 | TRVI |
Trevi Therapeutics, Inc.
|
525,000 | $6,263,250 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
75,000 | $6,246,750 | |
| 7 | CNTA |
Centessa Pharmaceuticals plc
|
150,000 | $5,958,000 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
100,000 | $5,815,000 |
All Filings in LXEO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $717,500 | 125,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,241,250 | 125,000 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||